Revelation Biosciences (REVB) Competitors $0.74 -0.02 (-2.33%) (As of 12:00 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends REVB vs. NLSP, WENA, SNSE, TLPH, NKGN, AWH, CDT, TSBX, INDP, and PHXMShould you be buying Revelation Biosciences stock or one of its competitors? The main competitors of Revelation Biosciences include NLS Pharmaceutics (NLSP), ANEW Medical (WENA), Sensei Biotherapeutics (SNSE), Talphera (TLPH), NKGen Biotech (NKGN), Aspira Women's Health (AWH), Conduit Pharmaceuticals (CDT), Turnstone Biologics (TSBX), Indaptus Therapeutics (INDP), and PHAXIAM Therapeutics (PHXM). These companies are all part of the "pharmaceutical products" industry. Revelation Biosciences vs. NLS Pharmaceutics ANEW Medical Sensei Biotherapeutics Talphera NKGen Biotech Aspira Women's Health Conduit Pharmaceuticals Turnstone Biologics Indaptus Therapeutics PHAXIAM Therapeutics NLS Pharmaceutics (NASDAQ:NLSP) and Revelation Biosciences (NASDAQ:REVB) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, media sentiment, earnings, analyst recommendations, community ranking, valuation and profitability. Does the media favor NLSP or REVB? In the previous week, Revelation Biosciences had 1 more articles in the media than NLS Pharmaceutics. MarketBeat recorded 2 mentions for Revelation Biosciences and 1 mentions for NLS Pharmaceutics. Revelation Biosciences' average media sentiment score of 1.02 beat NLS Pharmaceutics' score of 0.20 indicating that Revelation Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NLS Pharmaceutics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Revelation Biosciences 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer NLSP or REVB? Revelation Biosciences received 22 more outperform votes than NLS Pharmaceutics when rated by MarketBeat users. Likewise, 63.83% of users gave Revelation Biosciences an outperform vote while only 57.14% of users gave NLS Pharmaceutics an outperform vote. CompanyUnderperformOutperformNLS PharmaceuticsOutperform Votes857.14% Underperform Votes642.86% Revelation BiosciencesOutperform Votes3063.83% Underperform Votes1736.17% Is NLSP or REVB more profitable? NLS Pharmaceutics' return on equity of 0.00% beat Revelation Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets NLS PharmaceuticsN/A N/A N/A Revelation Biosciences N/A -193.51%-84.00% Which has more volatility and risk, NLSP or REVB? NLS Pharmaceutics has a beta of -0.51, indicating that its share price is 151% less volatile than the S&P 500. Comparatively, Revelation Biosciences has a beta of 0.15, indicating that its share price is 85% less volatile than the S&P 500. Which has better earnings and valuation, NLSP or REVB? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNLS PharmaceuticsN/AN/A-$12.17MN/AN/ARevelation BiosciencesN/AN/A-$120K-$16.76-0.04 Do insiders & institutionals hold more shares of NLSP or REVB? 12.8% of Revelation Biosciences shares are held by institutional investors. 16.4% of NLS Pharmaceutics shares are held by company insiders. Comparatively, 0.2% of Revelation Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryRevelation Biosciences beats NLS Pharmaceutics on 7 of the 10 factors compared between the two stocks. Ad Wyatt Investment ResearchMy #1 Pre IPO Trade for 2025 – NAME and TICKEROne tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report...The Next SpaceX Pre-IPO Get Revelation Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for REVB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart REVB vs. The Competition Export to ExcelMetricRevelation BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.18M$6.49B$5.09B$8.79BDividend YieldN/A8.11%5.04%4.07%P/E Ratio-0.045.3293.0914.02Price / SalesN/A370.921,220.6787.41Price / CashN/A52.5939.4936.27Price / Book1.2010.236.936.33Net Income-$120,000.00$153.22M$118.83M$225.71M7 Day Performance-11.42%-1.99%-1.74%-0.58%1 Month Performance-18.28%-7.51%-3.60%1.49%1 Year Performance-96.14%31.02%31.91%27.23% Revelation Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)REVBRevelation Biosciences0.5846 of 5 stars$0.74-2.3%N/A-96.1%$3.18MN/A-0.0410Positive NewsGap UpNLSPNLS Pharmaceutics1.2066 of 5 stars$3.32+0.9%N/A+623.1%$12.68MN/A0.006Gap DownWENAANEW MedicalN/A$0.73-0.5%N/AN/A$12.51MN/A0.00N/AGap UpSNSESensei Biotherapeutics4.8056 of 5 stars$0.48-3.6%$4.33+803.0%-20.0%$12.07MN/A0.0040News CoverageTLPHTalphera2.6915 of 5 stars$0.70-0.2%$4.50+538.4%N/A$12.00M$650,000.000.0019Gap UpNKGNNKGen BiotechN/A$0.33+4.5%N/A-89.1%$11.56M$80,000.00-0.06N/AGap UpAWHAspira Women's Health1.533 of 5 stars$0.70-3.6%$4.40+525.0%-78.5%$11.31M$9.15M-0.64110Analyst ForecastCDTConduit PharmaceuticalsN/A$0.11+23.1%N/A-92.8%$10.91MN/A0.003News CoverageGap UpHigh Trading VolumeTSBXTurnstone Biologics3.2023 of 5 stars$0.46+0.1%$2.13+361.5%-84.8%$10.65M$19.31M0.0082INDPIndaptus Therapeutics2.7304 of 5 stars$1.04-1.9%$8.50+717.3%-48.7%$10.61MN/A0.006PHXMPHAXIAM TherapeuticsN/A$3.10flatN/AN/A$10.58M$32.66M0.0049 Related Companies and Tools Related Companies NLS Pharmaceutics Competitors ANEW Medical Competitors Sensei Biotherapeutics Competitors Talphera Competitors NKGen Biotech Competitors Aspira Women's Health Competitors Conduit Pharmaceuticals Competitors Turnstone Biologics Competitors Indaptus Therapeutics Competitors PHAXIAM Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:REVB) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revelation Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revelation Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
